Dobrila-Dintinjana Renata, Nacinović-Duletić Antica
Clinic for Radiotherapy and Oncology, Rijeka University Hospital, Rijeka, Croatia.
Coll Antropol. 2011 Sep;35 Suppl 2:319-23.
Placebo is the use of the substance or procedure without specific activity for the condition that is trying to be healed. In medicine, benefits of placebo effect are used since 1985 and 1978 placebo effect was first scientifically confirmed. It was found that placebo induced analgesia depends on the release of endogenous opiates in the brain and that the placebo effect can be undone using the opiates antagonist naloxone. Functional magnetic resonance imaging of the brain showed that placebo analgesia was obtained regarding the activation and increased functional relationship between ant. cingulate, prefrontal, orbitofrontal, and insular cortex, nucleus accumlens, amygdala, periaqueduktalne gray matter and spinal cord. Placebo also facilitates descending inhibition of nociceptive reflexes through periacvaeductal gray substance. Placebo effect can be achieved in several ways: by using pharmacological preparations or simulation of operating or other procedures. This phenomenon is associated with perception and expectation of the patient. To achieve the effect of placebo it is essential degree of the suggestions of the person who prescribe a placebo, and the degree of belief of the person receiving the placebo. Expected effect of placebo is to achieve the same effect as the right remedy. Achieved placebo effect depends on the way of presentation. If a substance is presented as harmful, it may cause harmful effects, called 'nocebo" effect. Placebo effect is not equal in all patients, same as the real effect of the drug is not always equal in all patients. Application of placebo in terms of analgesia will cause a positive response in 35% of patients. Almost the same percentage (36%) of patients will respond to treatment with morphine in medium doses (6-8 mg). Therefore, one should remember that response to placebo does not mean that a person simulates the pain and then it is unethical to withhold the correct treatment especially in light of findings that the prefrontal cortex is activated expecting liberation of pain and how this action reduce activities in brain regions responsible for sensation of pain (thalamus, somatosensory cortex and other parts of the cortex). However, the use of placebos is ethically, legally and morally very dubious. The basis for the placebo effect is deception. It undermines honest relationship and trust between doctor and patient which is extremely important for successful treatment. Consciously giving placebos to patients for a condition that can be adequately treated, with prejudice the right of patients to the best care possible, opens up many bioethical issues. Despite all the current knowledge level, placebo effect remains still a scientific mystery.
安慰剂是指对试图治疗的病症使用没有特定活性的物质或程序。在医学中,自1985年起开始利用安慰剂效应的益处,1978年安慰剂效应首次得到科学证实。研究发现,安慰剂诱导的镇痛作用取决于大脑中内源性阿片类物质的释放,并且使用阿片类拮抗剂纳洛酮可以消除安慰剂效应。大脑的功能磁共振成像显示,安慰剂镇痛作用与前扣带回、前额叶、眶额叶和岛叶皮质、伏隔核、杏仁核、导水管周围灰质和脊髓之间的激活及功能关系增强有关。安慰剂还通过导水管周围灰质促进对伤害性反射的下行抑制。安慰剂效应可以通过几种方式实现:使用药物制剂或模拟手术或其他程序。这种现象与患者的感知和期望有关。要实现安慰剂效应,开安慰剂者的暗示程度以及接受安慰剂者的相信程度至关重要。安慰剂的预期效果是达到与正确药物相同的效果。所实现的安慰剂效应取决于呈现方式。如果一种物质被呈现为有害,它可能会产生有害影响,称为“反安慰剂”效应。安慰剂效应在所有患者中并不相同,就像药物的实际效果在所有患者中也不总是相同一样。在镇痛方面应用安慰剂会使35%的患者产生阳性反应。几乎相同比例(36%)的患者对中等剂量(6 - 8毫克)吗啡治疗有反应。因此,人们应该记住,对安慰剂有反应并不意味着一个人在假装疼痛,尤其是鉴于前额叶皮质在预期疼痛缓解时被激活以及这种作用如何减少负责疼痛感觉的脑区(丘脑、体感皮层和其他皮层区域)的活动,此时 withhold正确治疗是不道德的。然而,安慰剂的使用在伦理、法律和道德上非常值得怀疑。安慰剂效应的基础是欺骗。它破坏了医生和患者之间诚实的关系和信任,而这对于成功治疗极其重要。有意识地给患者使用安慰剂来治疗可以得到充分治疗的病症,会损害患者获得尽可能最佳治疗的权利,引发许多生物伦理问题。尽管有当前所有的知识水平,安慰剂效应仍然是一个科学谜团。